Three key considerations for deploying technology to help increase diversity in trials.
Kelly FitzGerald, PhD, CIP
Advertisement
IRB Executive Chair and Vice President, IBC Affairs, WCG
Articles by Kelly FitzGerald, PhD, CIP
Best practices in data re-identification and control when designing future trials.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
AI in Action: Breaking Down Clinical Trial Bottlenecks
4
Unlocking the Potential of Agentic AI to Reduce Trial Delays
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
